PT Itama Ranoraya Tbk (IDX:IRRA)
372.00
+2.00 (0.54%)
Sep 2, 2026, 1:30 PM WIB
PT Itama Ranoraya Tbk Financials Overview
Financials in millions IDR. Fiscal year is January - December.
Millions IDR. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 1,048,185 | 1,100,211 | 977,488 | 696,304 | 753,572 | 1,319,728 |
Revenue Growth | -15.02% | 12.55% | 40.38% | -7.60% | -42.90% | 134.04% |
Gross Profit Gross Profit Growth | 260,699 | 258,557 | 210,058 | 135,806 | 158,252 | 234,049 |
Operating Income Operating Income Growth | 102,647 | 100,680 | 92,126 | 26,795 | 75,058 | 149,379 |
Net Income Net Income Growth | 65,590 | 65,529 | 53,263 | 5,198 | 48,005 | 112,155 |
Earnings Per Share EPS Growth | 42.47 | 42.44 | 35.32 | 3.37 | 30.68 | 73.21 |
EPS Growth | -9.81% | 20.13% | 949.33% | -89.03% | -58.10% | 84.00% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Sterile Non-Electromedical Medical Equipment Sterile Non-Electromedical Medical Equipment Growth | 42,417 | 52,876 | 41,781 | 64,363 | 139,934 | 141,233 |
Electromedical Medical Equipment Electromedical Medical Equipment Growth | 473,483 | 347,939 | 534,880 | 412,612 | 43,875 | - |
In Vitro Diagnostic Products In Vitro Diagnostic Products Growth | 797,345 | 693,484 | 351,941 | 215,799 | 505,619 | 1,166,050 |
Others Others Growth | -265,061 | 5,912 | 48,886 | 3,530 | 64,143 | 12,445 |
Total Total Growth | 1,048,185 | 1,100,211 | 977,488 | 696,304 | 753,572 | 1,319,728 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 22,585 | 80,134 | 27,332 | 92,030 | 116,784 | 135,295 |
Total Debt Total Debt Growth | 1,072,042 | 835,916 | 619,843 | 240,862 | 160,207 | 80,000 |
Net Cash (Debt) Net Cash Growth | -1,049,457 | -755,782 | -592,512 | -148,832 | -43,423 | 55,295 |
Net Cash Growth | - | - | - | - | - | -76.22% |
Net Cash Per Share Net Cash Per Share Growth | -679.56 | -489.43 | -392.96 | -96.38 | -27.75 | 36.10 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 24,715 | -111,588 | -430,366 | -38,148 | -28,923 | -106,561 |
Capital Expenditures CapEx Growth | -375,366 | -53,427 | -25,659 | -34,803 | -4,438 | -18,371 |
Free Cash Flow Free Cash Flow Growth | -350,651 | -165,016 | -456,025 | -72,952 | -33,360 | -124,932 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 24.87% | 23.50% | 21.49% | 19.50% | 21.00% | 17.73% |
Operating Margin | 9.79% | 9.15% | 9.43% | 3.85% | 9.96% | 11.32% |
Pretax Margin | 7.58% | 7.15% | 7.18% | 1.13% | 8.29% | 10.98% |
Profit Margin | 6.26% | 5.96% | 5.45% | 0.75% | 6.37% | 8.50% |
FCF Margin | -33.45% | -15.00% | -46.65% | -10.48% | -4.43% | -9.47% |
| Fiscal Year | FY 2021 |
|---|---|
| Period Ending | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 18.750 |
Dividend Per Share Growth | 56.25% |
Dividend Yield | 0.96% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 8.71 | 9.76 | 11.32 | 240.44 | 35.17 | 28.18 |
PS Ratio | 0.53 | 0.58 | 0.62 | 1.80 | 2.24 | 2.39 |